All companies › AI

AI · C3.ai, Inc.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells2
Research cases0
Last filing2026-10-13

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-10-12 — Lath Hitesh · sold 20,000 @ $12.37 2026-10-13 — SIEBEL THOMAS M · sold 435,363 @ $11.82
2026-10-122026-10-13

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Lath Hitesh CHIEF FINANCIAL OFFICER
SIEBEL THOMAS M CEO and Chairman of the Board, Director, 10% owner
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $AI is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-10-13', 'insider_name': 'SIEBEL THOMAS M', 'insider_title': 'CEO and Chairman of the Board, Director, 10% owner', 'transaction_type': 'Open-market sell', 'shares': 435363.0, 'price': 11.8179, 'value': 5145076.4, 'is_buy': False}, {'transaction_date': '2026-10-12', 'insider_name': 'Lath Hitesh', 'insider_title': 'CHIEF FINANCIAL OFFICER', 'transaction_type': 'Open-market sell', 'shares': 20000.0, 'price': 12.37, 'value': 247400.0, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for AI today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.